MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.

Authors
Publication date
22 July 2023
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ezid

    redirect
    oaiark:/13030/qt68v541w1
    Last time updated on 24/08/2023